Your browser doesn't support javascript.
loading
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers-Zambia, July 2020.
Fwoloshi, Sombo; Hines, Jonas Z; Barradas, Danielle T; Yingst, Samuel; Siwingwa, Mpanji; Chirwa, Lameck; Zulu, James E; Banda, Dabwitso; Wolkon, Adam; Nikoi, Kotey I; Chirwa, Bob; Kampamba, Davies; Shibemba, Aaron; Sivile, Suilanji; Zyambo, Khozya D; Chanda, Duncan; Mupeta, Francis; Kapina, Muzala; Sinyange, Nyambe; Kapata, Nathan; Zulu, Paul M; Makupe, Alex; Mweemba, Aggrey; Mbewe, Nyuma; Ziko, Luunga; Mukonka, Victor; Mulenga, Lloyd B; Malama, Kennedy; Agolory, Simon.
Afiliação
  • Fwoloshi S; Zambia Ministry of Health, Lusaka, Zambia.
  • Hines JZ; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Barradas DT; Levy Mwanawasa Medical University, Lusaka, Zambia.
  • Yingst S; University of Zambia, School of Medicine, Lusaka, Zambia.
  • Siwingwa M; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Chirwa L; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Zulu JE; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Banda D; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Wolkon A; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Nikoi KI; Zambia Field Epidemiology Training Program, Lusaka, Zambia.
  • Chirwa B; Zambia National Public Health Institute, Lusaka, Zambia.
  • Kampamba D; Zambia Field Epidemiology Training Program, Lusaka, Zambia.
  • Shibemba A; Zambia National Public Health Institute, Lusaka, Zambia.
  • Sivile S; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Zyambo KD; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Chanda D; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Mupeta F; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Kapina M; Zambia Ministry of Health, Lusaka, Zambia.
  • Sinyange N; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Kapata N; Levy Mwanawasa Medical University, Lusaka, Zambia.
  • Zulu PM; University of Zambia, School of Medicine, Lusaka, Zambia.
  • Makupe A; Zambia Ministry of Health, Lusaka, Zambia.
  • Mweemba A; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Mbewe N; Levy Mwanawasa Medical University, Lusaka, Zambia.
  • Ziko L; University of Zambia, School of Medicine, Lusaka, Zambia.
  • Mukonka V; Zambia Ministry of Health, Lusaka, Zambia.
  • Mulenga LB; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
  • Malama K; Levy Mwanawasa Medical University, Lusaka, Zambia.
  • Agolory S; Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
Clin Infect Dis ; 73(6): e1321-e1328, 2021 09 15.
Article em En | MEDLINE | ID: mdl-33784382
BACKGROUND: Healthcare workers (HCWs) in Zambia have become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). However, SARS-CoV-2 prevalence among HCWs is not known in Zambia. METHODS: We conducted a cross-sectional SARS-CoV-2 prevalence survey among Zambian HCWs in 20 health facilities in 6 districts in July 2020. Participants were tested for SARS-CoV-2 infection using polymerase chain reaction (PCR) and for SARS-CoV-2 antibodies using enzyme-linked immunosorbent assay (ELISA). Prevalence estimates and 95% confidence intervals (CIs), adjusted for health facility clustering, were calculated for each test separately, and a combined measure for those who had PCR and ELISA was performed. RESULTS: In total, 660 HCWs participated in the study, with 450 (68.2%) providing a nasopharyngeal swab for PCR and 575 (87.1%) providing a blood specimen for ELISA. Sixty-six percent of participants were females, and median age was 31.5 years (interquartile range, 26.2-39.8). The overall prevalence of the combined measure was 9.3% (95% CI, 3.8%-14.7%). PCR-positive prevalence of SARS-CoV-2 was 6.6% (95% CI, 2.0%-11.1%), and ELISA-positive prevalence was 2.2% (95% CI, .5%-3.9%). CONCLUSIONS: SARS-CoV-2 prevalence among HCWs was similar to a population-based estimate (10.6%) during a period of community transmission in Zambia. Public health measures such as establishing COVID-19 treatment centers before the first cases, screening for COVID-19 symptoms among patients who access health facilities, infection prevention and control trainings, and targeted distribution of personal protective equipment based on exposure risk might have prevented increased SARS-CoV-2 transmission among Zambian HCWs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Africa Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Zâmbia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Africa Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Zâmbia